| Literature DB >> 28739029 |
Junhui Li1, Shuqiu Chen2, Xiang Xiao2, Yong Zhao3, Wenjun Ding4, Xian C Li5.
Abstract
CD4+ T cells have the capacity to differentiate into various T helper (Th) cell subsets after activation, and by acquiring distinct cytokine profiles and effector functions, they regulate the nature as well as the outcomes of immune responses. Th9 cells are a relatively new member in the Th cell family. The signature cytokine for Th9 cells is IL-9, a cytokine in the IL-2Rγc-chain family. Over the past few years, there has been an explosion of knowledge on the roles of Th9 cells in immunity and immunopathology, but the exact mechanisms in the control of Th9 cells remain poorly defined. This apparent paradox presents both challenges and opportunities. Here we review recent advances in our understanding of the fundamental biology of IL-9 and Th9 cells, highlighting the challenges and unanswered questions in the field. We also discuss potential opportunities in targeting Th9 cells for therapeutic purposes in the clinic.Entities:
Keywords: Immunity and immunopathology; Th9; Therapeutic purposes; Transcription mechanism
Mesh:
Substances:
Year: 2017 PMID: 28739029 PMCID: PMC5632571 DOI: 10.1016/j.cytogfr.2017.07.004
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638